FORTRESS BIOTECH INC (FBIO) Stock Analyst Ratings
NASDAQ:FBIO - Nasdaq - US34960Q3074 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to FBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.64. This target is 697.96% above the current price.
FBIO was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about FBIO.
In the previous month the buy percentage consensus was at a similar level.
FBIO was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-11 | Roth MKM | Reiterate | Buy -> Buy |
| 2024-11-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-05-16 | Roth MKM | Reiterate | Buy -> Buy |
| 2024-03-19 | Alliance Global Partners | Initiate | Buy |
| 2024-03-15 | Roth MKM | Reiterate | Buy |
| 2023-11-29 | Roth MKM | Maintains | Buy -> Buy |
| 2023-08-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-16 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-04-06 | Benchmark | Reiterate | Speculative Buy |
| 2022-08-04 | Ladenburg Thalmann | Initiate | Buy |
| 2022-07-14 | B. Riley Securities | Maintains | Buy |
| 2021-04-20 | Roth Capital | Maintains | Buy |